Literature DB >> 10744711

A novel marker for vertebrate embryonic heart, the EH-myomesin isoform.

I Agarkova1, D Auerbach, E Ehler, J C Perriard.   

Abstract

Myomesin is a structural component of the M-band that is expressed in all types of striated muscle. Its primary function may be the maintenance of the thick filament lattice and its anchoring to the elastic filament system composed of titin. Different myomesin isoforms have been described in chicken and mice, but no particular function has been assigned to them. Here we investigate the spatio-temporal expression pattern of myomesin isoforms by means of reverse transcriptase-polymerase chain reaction and isoform-specific antibodies. We find that two alternative splicing events give rise to four myomesin isoforms in chicken contrary to only one splicing event with two possible isoforms in mice. A splicing event at the C terminus results in two splice variants termed H-myomesin and S-myomesin, which represent the major myomesin species in heart and skeletal muscle of avian species, respectively. In contrast, in mammalian heart and skeletal muscle only S-myomesin is expressed. In embryonic heart of birds and mammals, alternative splicing in the central part of the molecule gives rise to the isoform that we termed EH-myomesin. It represents the major myomesin isoform at early embryonic stages of heart but is rapidly down-regulated around birth. Thus, the strict developmental regulation of the EH-myomesin makes it an ideally suited marker for embryonic heart.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744711     DOI: 10.1074/jbc.275.14.10256

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  M-band: a safeguard for sarcomere stability?

Authors:  Irina Agarkova; Elisabeth Ehler; Stephan Lange; Roman Schoenauer; Jean-Claude Perriard
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

2.  Half-sarcomere dynamics in myofibrils during activation and relaxation studied by tracking fluorescent markers.

Authors:  Ivo A Telley; Jachen Denoth; Edgar Stüssi; Gabriele Pfitzer; Robert Stehle
Journal:  Biophys J       Date:  2005-10-20       Impact factor: 4.033

3.  M-protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats.

Authors:  Andrei Rozanski; Ana Paula C Takano; Patricia N Kato; Antonio G Soares; Camilo Lellis-Santos; Juliane Cruz Campos; Julio Cesar Batista Ferreira; Maria Luiza M Barreto-Chaves; Anselmo S Moriscot
Journal:  Mol Endocrinol       Date:  2013-10-31

4.  Nonmuscle myosin IIB, a sarcomeric component in the extraocular muscles.

Authors:  Carole L Moncman; Francisco H Andrade
Journal:  Exp Cell Res       Date:  2010-03-27       Impact factor: 3.905

Review 5.  Cardiomyocyte cytoskeleton and myofibrillogenesis in healthy and diseased heart.

Authors:  E Ehler; J C Perriard
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

Review 6.  Cardiac Regeneration: Lessons From Development.

Authors:  Francisco X Galdos; Yuxuan Guo; Sharon L Paige; Nathan J VanDusen; Sean M Wu; William T Pu
Journal:  Circ Res       Date:  2017-03-17       Impact factor: 17.367

Review 7.  Overview of the Muscle Cytoskeleton.

Authors:  Christine A Henderson; Christopher G Gomez; Stefanie M Novak; Lei Mi-Mi; Carol C Gregorio
Journal:  Compr Physiol       Date:  2017-06-18       Impact factor: 9.090

8.  Plasticity of cardiac titin/connectin in heart development.

Authors:  Christiane A Opitz; Wolfgang A Linke
Journal:  J Muscle Res Cell Motil       Date:  2005       Impact factor: 2.698

9.  The sarcomeric M-band during development and in disease.

Authors:  Stephan Lange; Irina Agarkova; Jean-Claude Perriard; Elisabeth Ehler
Journal:  J Muscle Res Cell Motil       Date:  2005       Impact factor: 2.698

10.  A mouse model of uterine leiomyosarcoma.

Authors:  Katerina Politi; Matthias Szabolcs; Peter Fisher; Ana Kljuic; Thomas Ludwig; Argiris Efstratiadis
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.